PT Multi Indocitra Tbk (ISX:MICE) Other Current Liabilities: Rp16,800 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MICE PT Multi Indocitra Tbk ISX:MICE
91 GF Score
Price Rp520.00
GF Value Rp601.72
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is PT Multi Indocitra Tbk Other Current Liabilities?

PT Multi Indocitra Tbk ISX:MICE +4.00% 91 Other Current Liabilities is Rp16,800 Mil as of Mar. 2026. GuruFocus rates ISX:MICE with a GF Score™ of 91/100 and a GF Value™ of Rp601.72 (Modestly Undervalued). The stock has 5 warning signs investors should review.

PT Multi Indocitra Tbk's other current liabilities for the quarter that ended in Mar. 2026 was Rp16,800 Mil.

PT Multi Indocitra Tbk's quarterly other current liabilities declined from Sep. 2025 (Rp21,805 Mil) to Dec. 2025 (Rp18,762 Mil) and declined from Dec. 2025 (Rp18,762 Mil) to Mar. 2026 (Rp16,800 Mil).

PT Multi Indocitra Tbk's annual other current liabilities increased from Dec. 2023 (Rp11,977 Mil) to Dec. 2024 (Rp15,059 Mil) and increased from Dec. 2024 (Rp15,059 Mil) to Dec. 2025 (Rp18,762 Mil).


PT Multi Indocitra Tbk Other Current Liabilities Related Terms


PT Multi Indocitra Tbk Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for PT Multi Indocitra Tbk's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Multi Indocitra Tbk Other Current Liabilities Chart

PT Multi Indocitra Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,700.36 8,160.60 11,977.47 15,058.96 18,762.34

PT Multi Indocitra Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,793.52 18,950.45 21,805.16 18,762.34 16,800.21
ISX:MICE
91GF Score
PT Multi Indocitra Tbk ISX:MICE
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Multi Indocitra Tbk Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of Rp16,800 Mil mean?
PT Multi Indocitra Tbk (ISX:MICE) has a Other Current Liabilities of Rp16,800 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PT Multi Indocitra Tbk.
Is PT Multi Indocitra Tbk's Other Current Liabilities too high?
PT Multi Indocitra Tbk's current Other Current Liabilities is Rp16,800 Mil. Overall, PT Multi Indocitra Tbk has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Multi Indocitra Tbk's Other Current Liabilities compare to PG and CL?
PT Multi Indocitra Tbk's Other Current Liabilities of Rp16,800 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Consumer Packaged Goods company?
A good Other Current Liabilities depends on the Consumer Packaged Goods industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PT Multi Indocitra Tbk. PT Multi Indocitra Tbk's current Other Current Liabilities is Rp16,800 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Multi Indocitra Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Multi Indocitra Tbk (ISX:MICE) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp601.72, compared to a current price of Rp520.00 — trading 13.6% below its estimated fair value. The current Other Current Liabilities is Rp16,800 Mil. PT Multi Indocitra Tbk's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For PT Multi Indocitra Tbk (ISX:MICE), the current Other Current Liabilities is Rp16,800 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Multi Indocitra Tbk (ISX:MICE) Overvalued in 2026?

Based on GuruFocus' analysis, PT Multi Indocitra Tbk stock appears to be undervalued. The current stock price of Rp520.00 is trading 13.6% below its estimated GF Value™ of Rp601.72. GuruFocus considers PT Multi Indocitra Tbk to be Modestly Undervalued.

Key valuation signals for ISX:MICE:

  • Other Current Liabilities: Rp16,800 Mil
  • GF Value™: Rp601.72 vs. price of Rp520.00 (13.6% below fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the ISX:MICE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Multi Indocitra Tbk Business Description

Address Jalan Gajah Mada No. 188, Green Central City, Commercial Area, 6th Floor, Jakarta Barat, Glodok, Taman Sari, Jakarta, IDN, 11120
PT Multi Indocitra Tbk is mainly engaged in general trading of commercial baby's products and health care and cosmetics products. The Company produces and distributes consumer goods of baby and health care products and cosmetics. The company's Business segments are Trading, Services, and Industry. The company generates majority of revenue from Trading segment. The company's brands are Pigeon Baby, Pigeon Teens, Kaila, Kaila Beaute, Feira White, Mattel Indonesia, Youvit, HORI, HOYA, Lansinoh, Amara, Poipoi, Granova, Bumil.
91GF Score

Get the complete analysis for ISX:MICE

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp520.00
Price
Rp601.72
GF Value